Report

Protecting Public Health through Enhanced Oversight of Medical Products

The oversight of medical products was added to the High Risk List in 2009 because the Food and Drug Adminstration (FDA) was facing a variety of difficulties that threatened to compromise its ability to protect the public health. The 2009 report is updated here. While progress has been made, challenges remain. http://www.gao.gov/highrisk/protecting_public_health/why_did_study?utm_source=blog&utm_medium=social&utm_campaign=watchblog#t=0

SHARE:

TAGS:

COMMENTS

Report

Protecting Public Health through Enhanced Oversight of Medical Products

The oversight of medical products was added to the High Risk List in 2009 because the Food and Drug Adminstration (FDA) was facing a variety of difficulties that threatened to compromise its ability to protect the public health. The 2009 report is updated here. While progress has been made, challenges remain. http://www.gao.gov/highrisk/protecting_public_health/why_did_study?utm_source=blog&utm_medium=social&utm_campaign=watchblog#t=0

SHARE:

TAGS:

COMMENTS

Translate »